Ron Hunt is a Managing Director at New Leaf Venture Partners, where he invests across biopharmaceutical, healthcare technology, medical devices, and laboratory infrastructure technologies. He invests from seed and Series A through later stages, including Series B/C, post-IPO equity, and corporate rounds, with a focus on the United States and Europe, including Denmark. His investments include Harpoon Therapeutics, Iterum Therapeutics, Qlaris Bio, Electra Therapeutics, and Arine. Previously, he was a Partner at Sprout Group; a consultant in the pharmaceutical industry practice at Coopers & Lybrand Consulting and with The Health Care Group (a division of Interpublic Group); and worked in sales and marketing at Johnson & Johnson and SmithKline Beecham Pharmaceuticals. Ron graduated from The Wharton School and lives in New York, United States of America.
Ron Hunt, Managing Director @ New Leaf. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Ron Hunt from New Leaf Venture Partners. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Ron
Map your path to Ron instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Ron
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.